News

• Biogen Announces First Patient Treated in RESPOND Study Evaluating Benefit of SPINRAZA® (nusinersen) in Patients Treated With Zolgensma® (onasemnogene abeparvovec)
  01/08/2021 / 13:30 - GlobeNewswire
•  
• Catalyst Pharmaceuticals Announces Strategic Plan for Product Portfolio Expansion for Long-Term Success and Provides Corporate Update
  01/06/2021 / 14:07 - GlobeNewswire
•  
• Nordea Bank Abp: Flagging notification
  12/17/2020 / 20:32 - GlobeNewswire
•  
• Argus U.S. ESG Portfolio — Now Open to New SMA Investors
  12/15/2020 / 14:00 - GlobeNewswire
•  
• Nordea Bank Abp: Flagging notification
  12/02/2020 / 19:48 - GlobeNewswire
•  
• Nordea Bank Abp: Flagging notification in accordance with Chapter 9, Section 10 of the Securities Markets Act
  12/02/2020 / 12:05 - GlobeNewswire
•  
• Nordea Bank Abp: Flagging notification in accordance with Chapter 9, Section 10 of the Securities Markets Act
  12/01/2020 / 09:32 - GlobeNewswire
•  
• Eaglebrook Advisors Announces that Mariner Wealth Advisors is Making the Eaglebrook Bitcoin SMA Available to Clients
  11/17/2020 / 15:00 - GlobeNewswire
•  
• Catalyst Pharmaceuticals Announces Third Quarter 2020 Financial Results and Provides Business Update
  11/09/2020 / 23:20 - GlobeNewswire
•  
• Cytokinetics and Cure SMA Renew Partnership to Advance Education and Awareness of SMA
  08/26/2020 / 13:30 - GlobeNewswire
•  
• Catalyst Pharmaceuticals Announces Second Quarter 2020 Financial Results and Provides Business Update
  08/10/2020 / 22:15 - GlobeNewswire
•  
• Quest Strengthens Delivery of Modern Device Management with KACE Unified Endpoint Offerings
  07/29/2020 / 14:00 - GlobeNewswire
•  
• Biogen Plans to Initiate Phase 4 Study Evaluating Benefit of SPINRAZA® (nusinersen) in Patients Treated with Zolgensma® (onasemnogene abeparvovec)
  07/21/2020 / 13:30 - GlobeNewswire
•  
• Royalty Pharma Acquires Royalty Interest in Risdiplam From PTC Therapeutics
  07/20/2020 / 13:45 - GlobeNewswire
•  
• New Results From Landmark NURTURE Study Show That Pre-Symptomatic SMA Patients Treated With SPINRAZA® (nusinersen) Continue to Demonstrate Sustained Benefit From Treatment
  06/10/2020 / 13:30 - GlobeNewswire